Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceutical companies ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- AED 18.73T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | AED 251.4B | AED 78.67 | 1.02% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | AED 1.02T | AED 660.86 | 1.28% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | AED 1.08T | AED 573.74 | 1.83% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | AED 417.7B | AED 173.95 | 0.36% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | AED 2.44T | AED 1,013.72 | 0.97% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | AED 359.8B | AED 179.49 | 0.75% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | AED 4.57T | AED 5,135.27 | 1.23% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | AED 641.8B | AED 145.63 | 2.58% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | AED 21.2B | AED 31.15 | 1.74% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | AED 1.87T | AED 1,058.57 | 1.57% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | AED 1.26T | AED 509.14 | 3.31% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | AED 665.5B | AED 384.22 | 0.10% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | AED 170.2B | AED 1,490.02 | 1.83% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | AED 116.8B | AED 189.39 | 0.76% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | AED 500.5B | AED 1,974.22 | 0.62% up | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | AED 360.7B | AED 3,487.07 | 0.87% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | AED 146.8B | AED 255.28 | 1.20% up | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | AED 451.9B | AED 221.09 | 1.88% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | AED 590.2B | AED 103.54 | 0.98% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | AED 180.7B | AED 154.89 | 1.06% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | AED 46.1B | AED 55.26 | 1.72% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | AED 87.1B | AED 75.96 | 1.12% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | AED 28.3B | AED 81.10 | 4.55% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | AED 23.5B | AED 578.96 | 0.06% down | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | AED 74.5B | AED 555.91 | 3.29% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | AED 127B | AED 312.60 | 1.95% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | AED 91.2B | AED 2,141.76 | 0.17% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | AED 65.5B | AED 998.31 | 0.23% up | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | AED 26.9B | AED 307.53 | 1.99% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | AED 31.1B | AED 38.84 | 0.89% down | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | AED 27.5B | AED 350.39 | 0.30% up | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | AED 11.6B | AED 59.65 | 0.81% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | AED 26B | AED 494.45 | 0.98% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | AED 102.9B | AED 141.96 | 0.15% down | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | AED 97.2B | AED 443.21 | 0.98% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | AED 49.4B | AED 98.84 | 4.10% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | AED 14.6B | AED 106.73 | 1.09% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | AED 43.1B | AED 222.57 | 3.57% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | AED 19.3B | AED 457.39 | 0.88% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | AED 22.6B | AED 160.18 | 1.44% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | AED 27.5B | AED 251.01 | 2.47% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | AED 58.3B | AED 908.09 | 2.71% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | AED 34.9B | AED 1,501.87 | 3.10% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | AED 18.5B | AED 221.99 | 0.13% up | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | AED 24.1B | AED 355.50 | 0.49% up | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | AED 18.1B | AED 188.60 | 0.49% up | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | AED 22.2B | AED 339.32 | 0.47% up | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | AED 18B | AED 103.72 | 1.40% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | AED 17.4B | AED 49.58 | 2.81% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | AED 55.9B | AED 287.04 | 1.76% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | AED 16.8B | AED 153.60 | 0.52% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | AED 29B | AED 172.37 | 3.26% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | AED 33.8B | AED 355.68 | 3.23% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | AED 22.1B | AED 1,105.18 | 2.41% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | AED 17B | AED 101.92 | 2.93% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | AED 26.5B | AED 189.94 | 0.13% up | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | AED 31.7B | AED 1,135.33 | 1.33% up | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | AED 30.2B | AED 462.97 | 1.11% up | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | AED 18.1B | AED 321.69 | 0.70% up | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | AED 30.6B | AED 440.75 | 2.91% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | AED 36.8B | AED 243.18 | 5.58% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which pharmaceutical companies have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceutical companies ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of AED 18.73T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.